
|Articles|April 1, 1998
Supplements and Featured Publications
- Clinical and Economic Considerations of Helicobacter pylori Eradication and Screening
- Volume 4
- Issue 5 Suppl
Evaluation of Outcomes Achieved Through Peptic Ulcer Disease State Management
Author(s)Edward J. Drea, PharmD
Advertisement
Articles in this issue
almost 28 years ago
Participating Facultyalmost 28 years ago
The Impact of H Pylori Eradication on Your Pharmacy Budgetalmost 28 years ago
Overview of H pylori in Peptic Ulcer Diseasealmost 28 years ago
Clinical Issues and Cost Effectiveness of Treating H pylorialmost 28 years ago
Current Issues in H pylori Eradicationalmost 28 years ago
Is Curing Peptic Ulcer Disease an Oxymoron? A Focus on Helicobacter pylorialmost 28 years ago
CPE Quizalmost 28 years ago
Selected Abstractsalmost 28 years ago
BibliographyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
NYC Nurses Strike Enters Day 5 Amid Staffing, Safety, and Benefit Disputes
2
Long-term CR Seen With Allo-CAR-NK Cell Therapy Plus Rituximab in Waldenstrom NHL
3
CheckMate 9LA at 6 Years Shows Enduring Benefits From Dual Immunotherapy Plus Chemotherapy in Metastatic NSCLC
4
France Expands BOT–BAL Immunotherapy Access for Ovarian Cancer and Soft Tissue Sarcoma
5




























































